Guardant Health
GH
#1530
Rank
โ‚น1.220 T
Marketcap
โ‚น9,397
Share price
2.28%
Change (1 day)
205.18%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Cash on Hand

Cash on Hand as of September 2025 : โ‚น52.23 Billion

According to Guardant Health 's latest financial reports the company has โ‚น52.23 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Guardant Health - Cash on Hand chart (from 2017 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚น72.05 B-25.93%
2023-12-31โ‚น97.28 B16.26%
2022-12-31โ‚น83.67 B20.53%
2021-12-31โ‚น69.42 B-47.11%
2020-12-31โ‚น131.26 B252.1%
2019-12-31โ‚น37.28 B27.26%
2018-12-31โ‚น29.29 B107.3%
2017-12-31โ‚น14.13 B118.31%
2016-12-31โ‚น6.47 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Natera
NTRA
โ‚น93.87 B 79.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
โ‚น12.50 B-76.06%๐Ÿ‡บ๐Ÿ‡ธ USA